The drug resistance of Helicobacter pylori (H. pylori) is gradually becoming a serious problem. 21
of H. pylori to form biofilms on the gastric mucosa has been known. However, there are few 23 studies on the regulation mechanisms of H. pylori biofilm formation and multidrug resistance. 24
Guanosine 3'-diphosphate 5'-triphosphate and guanosine 3',5'-bispyrophosphate [(p)ppGpp] are 25 global regulatory factors and are synthesized in H. pylori by the bifunctional enzyme SpoT. It has 26 been reported that (p)ppGpp is involved in the biofilm formation and multidrug resistance of 27 various bacteria. In this study, we found that SpoT also plays an important role in H. pylori 28 biofilm formation and multidrug resistance. Therefore, it is necessary to carry out some further 29 studies regarding its regulatory mechanism. Considering that efflux pumps are of great importance 30 in the biofilm formation and multidrug resistance of bacteria, we tried to find if efflux pumps 31 controlled by SpoT participate in these activities. Then, we found that Hp1174 (glucose/galactose 32 transporter, gluP), an efflux pump of the MFS family, is highly expressed in biofilm-forming and 33 multi-drug resistance (MDR) H. pylori and is upregulated by SpoT. Through further research, we 34 determined that gluP involved in H. pylori biofilm formation and multidrug resistance. 35 Furthermore, the average expression level of gluP in clinical MDR strains was considerably 36 higher than that in clinical drug-sensitive strains. Taken together, our results revealed a novel 37 molecular mechanism of H. pylori tolerance to multidrug. 38
INTRODUCTION 40
Helicobacter pylori, whose infection rate is over 50 percent throughout the world, is highly 41 associated with a wide range of upper gastrointestinal diseases, especially gastric carcinoma (1) . 42
Contemporarily, the most common treatment method for this bacteria is called triple therapy, 43 which consists of a proton-pump inhibitor and two antibiotics, namely, macrolides, 44 nitroimidazoles or β-lactam(2). However, in recent years, eradication of H. pylori is becoming 45 increasingly difficult because the rate of antibiotic resistance acquisition by H. pylori has 46 generally increased(3). In addition, with the extended use of antibiotics, the appearance of 47 multidrug-resistant (MDR) H. pylori strains, which are resistant to multiple antibiotics, has been 48 reported(4). 49
There are numerous molecular mechanisms that contribute to multiple antibiotic resistance in the 50 bacteria, including decreased drug permeability, efflux pumps, alteration or bypass of the drug 51 target, production of antibiotic-modifying enzymes, and other physiological states, such as the 52 formation of biofilms(5). Biofilms are communities of microorganisms anchored to a surface, 53 which live in an extracellular matrix called extracellular polymeric substances (EPS) that they 54 produce to form their immediate environment(6). The property that makes biofilms distinct from 55 planktonic cells is their increased resistance to antimicrobial agents. Recently, it has become 56 widely accepted that the biofilm plays an imperative part in the pathogenesis of some chronic 57 human infections, as well as bacterial multidrug resistance(6, 7). Furthermore, it has already been 58 reported that H. pylori has the ability to form biofilms in vitro(8). Then, in 2006, using scanning 59 electron microscopy, Carron MA et al first proposed that H. pylori can form biofilms in vivo(9). 60
The formation of biofilms in vivo is an important cause of H. pylori resistance to multiple 61 antibiotics(10), while the stringent response to the stressful environment that lacks nutrients 62 contributes to the resistance as well(11). 63
The stringent response is a bacterial stress response that controls bacterial adaptation to stress 64 signals such as nutrient deprivation(12). In bacteria, the signal molecule (p)ppGpp, which is 65 induced by diverse stresses, activates the stringent response(12, 13).The phenomenon of (p)ppGpp affecting bacterial multidrug resistance has already been reported for some other bacteria(14). 67
Maisonneuve et al reported that under antibiotic stress, E. coli can produce rare cells that 68 transiently become multidrug tolerant. In these rare cells, the level of (p)ppGpp was high(15). In 69 addition, it has also been proven that (p)ppGpp can affect the formation of the bacterial biofilm. 70 Nevertheless, there are still no reports certifying the relationship between (p)ppGpp and the 74 formation of biofilms in H. pylori. 75
In many bacteria, such as E.coli, (p)ppGpp is synthesized by two enzymes, RelA and SpoT(18), 76
and SpoT is a bifunctional enzyme with both (p)ppGpp synthetase activity and hydrolase 77 activity(18). However, there is only one member of RelA/SpoT family-SpoT-in the H. pylori 78 genome(19); therefore, in H. pylori, we focused on whether SpoT is involved in H. pylori biofilm 79 formation and multidrug resistance 80
There are a series of transport proteins in bacteria, which can acquire nutrients and extrude 81 metabolic by-products, and some of these proteins are called efflux pumps(20). Efflux pumps have 82 the ability to expel a broad range of antibiotics and have been recognized as significant 83 components of multidrug resistance in many bacteria(21, 22), such as H. pylori (23) (24) (25) (26) (27) (28) (29) Considering that SpoT is a global regulator, we suppose that SpoT can influence the formation of 92 biofilms and multidrug resistance by regulating the expression of the efflux pump in H. pylori. 93
RESULTS 94

SpoT is involved in H. pylori biofilm formation and multidrug resistance 95
As a global regulatory factor, SpoT has been proven to participate in the formation of bacterial 96 biofilms(16, 17, 35), while no related studies have been done regarding H. pylori. Therefore, we 97 analyzed the expression difference of spoT between biofilm-forming and planktonic cells by 98 RT-PCR. The gene spoT is highly expressed in the latter (Fig. 1A) . The (p)ppGpp assay shows that 99 H. pylori in the biofilm produces more (p)ppGpp than the planktonic cells ( Fig. 1B) . By 100 constructing a spoT mutant strains, we compared the biofilm of the wild-type and ΔspoT strains by 101 GLSM (Fig. 1D ) and SEM (Fig.1E ). The wild-type strains could form complete and compact 102 biofilms on the NC membrane, whereas for the biofilm of the ΔspoT strains, the bacteria were not 103 packed tightly enough and the biofilm matrix was not complete, and some cavities could be seen 104 According to the MIC of the wild-type strains and the ΔspoT strains, for planktonic cells, the 107
ΔspoT strains are apparently more sensitive to various antibiotics than the wild type, and 108 ciprofloxacin is not included (Tab. 2). With regard to the biofilm-forming cells, after knocking out 109 spoT, the cell resistance to various antibiotics is reduced, especially for penicillin G (Tab. 2). Then, we treated the wild-type and ΔspoT strains with the MIC of the antibiotics (CLA, AMO, TET and 111 MET). The growth inhibitory curve demonstrates that the growth ability of the ΔspoT strains are 112 obviously inhibited (Fig. 2) . 113
Comparing the efflux capacity of wild and ΔspoT strains 114
As SpoT is involved in the formation of the biofilm and multidrug resistance of H. pylori, and an 115 efflux pump contributes to them as well(22, 30), we inferred that SpoT could possibly carry out 116 those functions by regulating the expression of efflux pump. Therefore, we compared the efflux 117 activity of the wild-type and ΔspoT strains. The results reveal that whether in biofilm-forming or 118 planktonic cells, the inactivation of SpoT caused a distinct increase in the accumulation of 119
Hoechst 33342, notably for planktonic cells, and the fluorescence values of the ΔspoT strains 120 were >3-fold greater than those of the WT. These results demonstrate that the efflux activity of 121
ΔspoT strains to Hoechst 33342 is weaker than that of the wild-type strains ( Fig. 3) , which 122 suggests that SpoT is likely to regulate the efflux pump gene expression of H. pylori. 123
Screening efflux pumps involved in the formation of biofilms and multidrug resistant in H. 124 pylori by qRT-PCR 125
There are six families of bacterial efflux pumps: (1) the ATP-binding cassette (ABC) superfamily; 126
(2) the major facilitator superfamily (MFS); (3) the multidrug and toxic compound extrusion 127 (MATE); (4) the small multidrug resistance (SMR) family; (5) the resistance-nodulation-division 128 (RND) superfamily; and (6) the drug metabolite transporter (DMT) superfamily(30). It is 129 generally agreed that ABC, MFS and RND family play important roles in gram-negative 130 bacteria(30). As extensive studies regarding RND family in H. pylori have been conducted so 131 far(8, 25, 29, 34), we analyzed the expression difference of some efflux pumps belonging to the 132 As seen from the table, the expression levels of two particular genes had greater than three-fold 134 increases within biofilm-forming cells compared those in to planktonic cells: hp1181 and 135 hp1174(gluP). Furthermore, we analyzed the mRNA expression difference of these two genes in 136 multidrug-resistant H.pylori (MDR-H, artificially selected), and only gluP was highly expressed, 137 compared to that in the sensitive strains ( Fig. 4 ). Considering that SpoT shows high expression in 138 MDR-H (Fig. 4 ) strains and biofilm-forming cells, we proposed that SpoT may participate in the 139 formation of biofilm and multidrug resistance of H. pylori by upregulated gluP. 140
SpoT regulates GluP expression 141
To verify if GluP is regulated by SpoT, we chose three antibiotics (CLA, AMO and MET) to treat 142 the wild-type strains and ΔspoT strains. First, we used three kinds of antibiotics with different 143 concentrations to stimulate the wild-type and ΔspoT strains for 10 min; then we treated the 144 wild-type strains and the ΔspoT strains at a specific concentration of the three antibiotics along a 145 time gradient. The results of qRT-PCR showed that AMO and MET can both induce the 146 expression of gluP in wild-type strains compared to that in the control group (wild-type strains 147 without antibiotics treatment), doing so in a concentration-and time-dependent manner, while in 148 the ΔspoT strains, GluP can barely be induced by these two antibiotics ( Fig. 5 ). However, CLA 149 can hardly induce the expression of gluP, and the sensitivity of wild and ΔspoT strains to CLA is 150 similar according to MIC data. This suggests that gluP may not be involved in the resistance of H. 151 pylori to CLA. In short, the results above indicate that SpoT upregulates GluP to cope with 152 specific antibiotics stress. 153
GluP involved in H. pylori efflux 154
GluP, a glucose transporter, is responsible for glucose transport in H. pylori (19) . In addition, the 155 analysis of structure demonstrates that GluP is an efflux pump belonging to MFS family, which 156 suggests that GluP is likely to take part in drug efflux in H. pylori. Therefore, we successfully 157 constructed gluP mutant strains and compared the efflux capacity of wild-type strains and ΔgluP 158 strains. The results reveal that whether in biofilm-forming and planktonic cells, the inactivation of 159
GluP caused a distinct increase in the accumulation of Hoechst 33342, especially for planktonic 160 cells, and the fluorescence values of the ΔgluP strains were >3-fold greater than those of the 161 wild-type strains. These results showed that ΔgluP strains had lower efflux capacity for Hoechst 162 33342 than that of wild-type strains, both in planktonic and biofilm-forming cells ( Fig. 6) . 163
Glup is involved in H. pylori biofilm formation and multidrug resistance 164
Studies have reported that efflux pumps participate in bacterial biofilm formation(30), so we 165 compared biofilms of wild-type strains and ΔgluP strains by SEM. The images showed that 166 compared with the wild-type strains, bacteria in the ΔgluP strain biofilm were not tightly packed, 167 and the biofilm matrix was incomplete and showed more cavities (Fig. 7A ). By GLSM, LIVE / 168 DEAD cell viability assays showed that the ΔgluP strains form a thinner biofilm ( Fig According to the MIC of the wild-type strains and ΔgluP strains from planktonic cells (Tab. 2), the 170
ΔgluP strains are apparently more sensitive to various antibiotics than the wild-type strains, except 171 for clarithromycin and ciprofloxacin. After knocking out gluP in MDR-H strains, its resistance to 172 drugs also dropped significantly, especially for amoxicillin (Tab. 2). In addition, for those 173 biofilm-forming cells, after knocking out gluP, its sensitivity to various antibiotics increased (Tab. 174
2). 175
We treated wild-type strains and ΔgluP strains separately with the MIC (of wild strains) of three antibiotics (CLA, AMO and MET) and then observed their growth inhibition curve. The results 177
showed that compared with the wild-type strains, the growth ability of the ΔgluP strains was 178 significantly inhibited by AMO and MET, but not CLA (Fig. 8) . The above results suggest that 179
GluP may not be involved in planktonic H. pylori's tolerance to clarithromycin, which is 180 consistent with the results of MIC. 181
The relative mRNA expression levels of gluP were assessed by qRT-PCR in clinical MDR strains 182
and clinical sensitive strains. The average expression levels of gluP in clinical MDR strains were 183 significantly higher than those in sensitive ones ( Fig. 9 ). 184
185
DISCUSSION 186
Recently, antibiotic resistance acquired by H. pylori has generally increased, and the formation of 187 biofilms in vivo is an important cause leading to its multidrug resistance(10). In this research, we 188 found that SpoT is involved in the formation of biofilm in H. pylori. While it has been reported 189 that efflux pump takes part in the formation of biofilms and multidrug resistance(30), we found 190 that gluP is involved in the biofilm formation and multidrug resistance of H. pylori. Further 191 analysis showed that the expression of gluP was upregulated by SpoT. Considering that SpoT is a 192 global regulator, our study partly explained the molecular mechanism of SpoT involved in the 193 biofilm formation of H. pylori and multidrug resistance. The formation of biofilm is another important factor that causes multidrug resistance in bacteria (7). 202
Biofilms are communities of microorganisms anchored to a surface, living in an extracellular 203 matrix called extracellular polymeric substances (EPS), which are produced by the organisms to 204 form their immediate environment(7). Bacteria with biofilms have strong resistance to antibiotics 205 and host immune defenses(6). It has been reported that (p)ppGpp is involved in the formation of 206 biofilm in various bacteria, but the function of (p)ppGpp during this process varies from species to 207 species. Several previous studies showed that the lack of (p)ppGpp resulted in decreased biofilm 208 formation in bacteria, such as Enterococcus faecalis(35), Vibrio cholerae(41) and Bordetella 209 pertussis(16). However, other studies proved that (p)ppGpp-synthase deletion mutants of 210 Actinobacillus pleuropneumoniae(17) and Francisella novicida(42) could produce significantly 211 more biofilms than the wild type. Since SpoT is the only gene that plays a part in the synthesis of 212 (p)ppGpp in H. pylori, its ability to synthesize (p)ppGpp is totally lost after the knockout of SpoT, 213 consequently lowering its ability to adapt to stressful environments. In this study, we induced H. 214 pylori to form a biofilm through nutrient starvation, because nutrition deficiency is a significant 215 factor that induces bacteria to form biofilms. After spoT knockout, the ability of H. pylori to form 216 biofilms was greatly reduced. 217
The formation of biofilms is an important cause of multidrug resistance in bacteria, and 218 biofilms lead to continuous chronic infections, which add to the difficulty in providing a clinical 219 cure(6). Drug resistance mechanisms include the following: poor diffusion of antibiotics through 220 the biofilm polysaccharide matrix, physiological changes due to the slow growth rate and 221 starvation responses that form persistent cells, phenotypic changes of the cells forming the biofilm, 222 the expression of efflux pumps, and so on(7). Drug efflux is a key mechanism of drug resistance in 223 gram-negative bacteria(21). Microorganisms regulate the internal environment to adapt to their 224 outer circumstances by excluding poisonous substances (microbial agents, metabolite and quorum 225 sensing chemical signals) via efflux pumps(22). Normally, the expression of efflux pumps in 226 biofilm-forming bacteria is higher than that in planktonic cells(30). For example, in P. aeruginosa, 227 the mechanism for tolerance to collistin is the upregulation of the MexAB-OprM efflux pump in 228 biofilms(43). Moreover, in E. coli, when growing in biofilms and exposed to several antibiotics, 229
AcrAB-TolC efflux pump-encoded genes are upregulated(44). In addition, the expression levels of 230 the acrA and acrB genes are observed to increase in Salmonella biofilm cells(45). It has been 231 reported that the RND family of efflux pumps are highly expressed in H. pylori biofilms(34), and 232 recent studies have shown that hp1165 and hefA are highly expressed in clinically isolated H. 233 pylori biofilms(46). In our research, the expression of several efflux pumps is high in H. pylori 234 biofilms. Some further studies regarding gluP found that it took part in the formation of H. pylori 235 biofilms. After gluP knockout, the H. pylori biofilm matrix is damaged and unable to form a 236 well-structured biofilm. Some studies confirmed that the extremely low biofilm formation in the 237 wild type can be observed in E. coli mutants without emrD, emrE, emrK, acrD, acrE and mdtE 238 efflux pump-encoding genes(47). Efflux pumps are involved in biofilm formation, which is 239 possibly due to the export or import of some substances related to forming biofilms. gluP is a 240 glucose/galactose transporter, belonging to the major facilitator superfamily (MFS)(19), which is 241 mainly responsible for the physiological uptake of sugars, such as D-glucose, into H. pylori. 242 D-Glucose is involved in the synthesis of bacterial exopolysaccharides, while polysaccharides 243 account for a major fraction of the biofilm matrix(48). Therefore, the deletion of gluP may affect 244 the synthesis of the H. pylori biofilm matrix. We found that the matrix of the H. pylori biofilm was 245 incomplete after gluP knockout, even if the concentration of glucose in the medium was increased 246 (supplementary, Fig S1) . In addition, the biofilm matrix can limit the transport of some 247 antimicrobial agents to cells within the biofilm(7). 248 Niehus and coworkers, the promoter sequence of σ 54 -dependent genes is TTTGCTT(52). By 257 analyzing the upstream sequence of the putative ATG start codon of the ORFs of gluP, we 258 discovered a possible conserved sequence (TTTGCAT) that was recognized by σ 54 (supplementary, 259 Fig. S2 ), which suggests that gluP could be regulated by σ 54 . In further studies, antibiotic 260 treatment could not induce high gluP expression in the σ 54 mutant strains (supplementary, Fig. S3 ). 261
Therefore, SpoT may upregulate the expression of gluP by controlling σ 54 , but detailed 262 mechanisms require more studies. 263
In conclusion, this research has discovered a new mechanism regarding the formation of the 264 biofilms and multidrug resistance in H. pylori. It must be admitted that further analysis is required 265 to prove specific mechanisms of how SpoT regulates H. pylori biofilm formation. On account of 266 the present data, our research provides evidence and clues for the clinical treatment of 267 drug-resistant strains and epidemiological investigation. 
Assessment of susceptibility to antibiotics 286
The minimal inhibitory concentrations (MICs) of all the clinical and standard strains for various 287 antibiotics were determined by the Etest and the agar dilution method reported by Osato et al.(53) . 288
The bacteria (optical density at 600 nm [OD600], 0.8) were inoculated on an agar plate containing 289 2-fold dilutions of antibiotics. All the plates were incubated at 37°C under microaerobic 290 conditions, and MIC values were determined. The determination of biofilm-forming bacterial 291
MICs was similar to that for the planktonic bacteria. The biofilm, which was attached to the NC 292 membrane, was incubated in a liquid medium containing different concentrations of various 293 antibiotics for 12 h. After being washed three times with PBS, the biofilm bacteria were suspended 294 in liquid culture medium, and this liquid was inoculated on an agar plate to determine the MIC 295 values. 296
Construction of biofilm 297
The biofilm could be cultivated in two kinds of conditions: the static condition or the continuous 298 flow condition. There were many ways to cultivate biofilms under the static condition, among 299 which we used the "colony biofilm" (described in previous article(54, 55)) with slight 300 modifications. To allow the adherence of H. pylori at the interface, 20 μl of bacteria were 301 inoculated at 5×10 7 cells ml -1 onto a nitrocellulose membrane (approximately 1×1 cm 2 ), which 302 was placed on an agar plate. The agar plate was cultured in a microaerobic environment (5% O 2 , 303 10% CO 2 , and 85% N 2 ) at 37°C for 3 days. 304
Scanning electron microscopy 305
To observe the H. pylori biofilm, SEM (scanning electron microscopy) was used. The samples for 306 SEM were prepared along the following standard procedures. Planktonic bacteria were fixed with 307 glutaraldehyde after centrifugation. For the biofilm-forming bacteria, the samples were gently washed with autoclaved PBS three times to remove planktonic bacteria. The biofilms were fixed 309 in 2.5% glutaraldehyde at 4°C for 2 h and then washed three times with cacodylate buffer and 310 dehydrated through a series of graded ethanol solutions (25%, 50%, 75%, 95% and 100%). 311
Subsequently, the samples were freeze-dried, sputter coated with gold, and observed by a scanning 312 electron microscope. 313
Confocal laser scanning microscopy (CLSM) 314
To determine bacterial shape and viability, planktonic H. pylori were stained with 315
membrane-permeable and membrane-impermeable fluorescent dyes from the Live/Dead BacLight 316
Bacterial Viability kits (Molecular Probes, Invitrogen, USA). Then, they were observed by 317 confocal microscopy, which was performed according to a previous study(40). For 318 biofilm-forming cells, the NC membrane with the biofilm was removed from the agar plate and 319 then gently washed three times with PBS. Subsequently, the NC membrane was stained in a 320 12-well plate with 1 ml Syto 9 dye for 20 mins in the dark conditions and gently washed three 321 times with PBS. After that, the NC membrane was fixed on a slide, covered with a coverslip and 322 subsequently analyzed with a confocal laser scanning microscope (Leica TCS SP5; Leica 323
Microsystems GmbH, Wetzlar, Germany). Syto 9 is a green fluorescent membrane-permeable dye 324 that labels all bacteria by the staining nucleic acid, whereas PI is a red fluorescent 325 membrane-impermeable dye that only labels bacteria with damaged membranes. 326
Detection of (p)ppGpp accumulation patterns 327
The (p)ppGpp production was assayed according to the previous literature with slight 328 modification(40). The treatment of the planktonic bacteria was the same as previously described. 329
For the biofilm bacteria, first, they were washed with PBS, then diluted to an OD600 of 0.2, and incubated for an additional 2 h. When all the strains reached an OD600 of approximately 0.3, the 331 samples of each culture plate were centrifuged at 10,000 rpm for 5 min, and resuspended in 250 μl 332 of liquid culture medium. 32 P (Amersham) was added to 100 μCi ml -1 , and the cultures were 333 labeled for 2 h at 37°C. Then, 50 μl of each sample was added to an equal volume of 2 M formic 334 acid. Afterward, at least four freeze-thaw cycles were conducted. The acid extracts were briefly 335 centrifuged, and the supernatant fluids were spotted onto the polyethyleneimine-cellulose plates 336 (Sigma-Aldrich), dried, and developed in 1.5 M KH 2 PO 4 (pH 3.4) for approximately 2.5 h. The 337 results were obtained under phosphor screen scanning (Bio-Rad). 338 339
Extraction of RNA and Real-time Quantitative PCR (qRT-PCR) 340
The total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). To reverse 341 transcribe the total RNA, the PrimeScript RT Reagent kit with gDNA Eraser (TaKaRa) was used. 342
Primers are shown in Table 1 . In the 20 μl qPCR mixtures, 5 μl of the resulting cDNA, which was 343 already diluted, 10 μl of SYBR Premix Ex TaqTM (TaKaRa, Otsu, Shiga, Japan), 0.8 μl of the 344 primer mixture, and 4.2 μl of double-distilled water were added. Then, RT-PCR was done using 345 the ABI Prism 7000 Sequence detection system (Applied Biosystems, Carlsbad, CA) for 1 cycle at 346 95°C for 30 s and 40 cycles at 95°C for 5 s and 60°C for 31 s. Dissociation curve analysis was 347 performed to verify the product homogeneity. The 16S rRNA amplicon was used as an internal 348 control for data normalization. Changes in the transcript level were determined by applying the 349 relative quantitative method (ΔΔC T ). The threshold cycle (C T ) values from all three biological 350 replicates for each strain were compiled. 351
Construction of hp1174(gluP) mutant strains
The plasmids pILL570 and pUC18K2 were kindly provided by Agnès Labigne (Unité de  353 Pathogénie Bactérienne des Muqueuses, Institut Pasteur). The construction of the gluP mutant 354 strains was identical to the construction of the ΔspoT strains, as described in the previous literature 355 (56). Briefly, the genome of H. pylori 26695 was extracted to serve as a template. Primers are 356 listed in Table 1 . The gene hp1174 was destroyed with the insertion of the nonpolar aphA-3 gene 357 encoding a kanamycin resistance cassette. 358
Determination of growth curves and growth inhibition curves 359
The determination of the growth curves was consulted in the previous literature(40). The growth 360 profiles were monitored in Brucella broth with a preliminary OD600 of 0.08 and then cultured for 361
another 144 h at 37°C with shaking. Records were taken every 12 h by determining the OD600 of 362 the test strains. The values stated are the mode values from at least three biological replicates 363 performed in at least three independent occasions. 364
To analyze the growth inhibition curve, the H. pylori strains were inoculated into Brucella broth 365 with a preliminary OD600 of 0.08, which also contains different kinds of antibiotics (MIC of wild 366 strains), and then cultured for another 144 h at 37°C with shaking. Each experiment was repeated 367 at least three times. 368
H33342 accumulation assay 369
For the planktonic bacteria, the accumulation assay method was performed as described 370 previously(40). The biofilm bacteria was first rinsed off with PBS and subsequently suspended in The present research was supported by the National Natural Science Foundation of China (No. 396 81471991, 81671978, 81460314, 81374101 and 81571960). 397
We declare that we have no conflicts of interest. 398 REFERENCE 399 ΔspoT strains exposed to different drug concentrations for 10 min (A) and exposed to special drug 576 concentrations for different time periods (B). The results were compared to the WT without drug 577 treatment (CTL). The signal was normalized to the 16S rRNA levels. Data are the means ±SEM 578 from three independent experiments. Significance was determined by paired t test: **, P < 0.01; 579 ***, P <0.001. 580 
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